Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,908 | 3,559 | 5,018 | 4,307 | 3,471 |
| Receivables | 4,422 | 2,944 | 2,198 | 4,496 | 2,777 |
| Inventories | 2,735 | 2,405 | 2,325 | 2,131 | 1,639 |
| Other current assets | 0 | 214 | 211 | 208 | 206 |
| TOTAL | $14,607 | $9,852 | $10,579 | $12,483 | $9,110 |
| Non-Current Assets | |||||
| PPE Net | 965 | 912 | 872 | 887 | 718 |
| Intangibles | 1,018 | 1,091 | 1,163 | 1,236 | 1,308 |
| Other Non-Current Assets | 140 | 138 | 152 | 55 | 126 |
| TOTAL | $2,123 | $2,141 | $2,188 | $2,178 | $2,153 |
| Total Assets | $16,730 | $11,993 | $12,766 | $14,661 | $11,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 900 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,805 | 2,629 | 3,489 | 1,773 | 1,914 |
| Accrued Expenses | 4,296 | 3,981 | 886 | 3,278 | 847 |
| TOTAL | $8,101 | $6,609 | $5,861 | $6,298 | $5,401 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,000 | 10,000 | 11,350 | 10,000 | 11,100 |
| Other Non-Current Liabilities | 8,082 | 4,493 | 0 | 0 | 0 |
| TOTAL | $22,303 | $18,530 | $15,300 | $10,000 | $11,100 |
| Total Liabilities | $30,404 | $25,139 | $21,161 | $16,298 | $16,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,913 | 4,432 | 4,432 | 4,432 | 4,432 |
| Common Shares | 363 | 355 | 355 | 355 | 343 |
| Retained earnings | -144,568 | -140,201 | -135,497 | -128,763 | -126,884 |
| Other shareholders' equity | 163 | 105 | 83 | 60 | 32 |
| TOTAL | $-13,675 | $-13,146 | $-8,395 | $-1,637 | $-5,239 |
| Total Liabilities And Equity | $16,729 | $11,993 | $12,766 | $14,661 | $11,262 |